Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Birgitte Jacobsen"'
Autor:
Gabriella Alexandersson von Döbeln, Gunnar Wagenius, Eva Holtved, Anne-Birgitte Jacobsen, Magnus Nilsson, Jingru Yu, Lene Baeksgaard
Publikováno v:
Cancer Treatment and Research Communications, Vol 24, Iss , Pp 100187- (2020)
Background: Chemoradiotherapy is standard treatment for localized oesophageal cancer unsuitable for surgery. We aimed to evaluate the efficacy of cetuximab in combination with chemoradiotherapy. Methods: This non-randomised multicentre phase II trial
Externí odkaz:
https://doaj.org/article/49e87bf593ef447999c7d68faeae26d0
Autor:
Terje Osnes, Eva Sigstad, Krystyna Kotanska Grøholt, Bianca Lorntzsen, Anne Birgitte Jacobsen, Ragnhild Sørum Falk
Publikováno v:
European Archives of Oto-Rhino-Laryngology. 274:4203-4209
Anaplastic carcinoma of the thyroid gland (ATC) is one of the most aggressive cancers in humans. With insufficient treatment, the disease most often leads to death in suffocation. From 2002, our treatment strategy has been hyperfractionated accelerat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b4705b32abb72b77a18da60bb513cbb
https://doi.org/10.1007/s00405-017-4764-8
https://doi.org/10.1007/s00405-017-4764-8
Autor:
Jingru Yu, Lene Baeksgaard, Magnus Nilsson, Eva Holtved, Anne Birgitte Jacobsen, Gunnar Wagenius, Gabriella Alexandersson von Döbeln
Publikováno v:
von Döbeln, G A, Wagenius, G, Holtved, E, Jacobsen, A B, Nilsson, M, Yu, J & Baeksgaard, L 2020, ' Definitive chemoradiotherapy plus cetuximab for cancer in the oesophagus or gastro-oesophageal junction ', Cancer Treatment and Research Communications, vol. 24, 100187 . https://doi.org/10.1016/j.ctarc.2020.100187
Cancer Treatment and Research Communications, Vol 24, Iss, Pp 100187-(2020)
Cancer Treatment and Research Communications, Vol 24, Iss, Pp 100187-(2020)
Background Chemoradiotherapy is standard treatment for localized oesophageal cancer unsuitable for surgery. We aimed to evaluate the efficacy of cetuximab in combination with chemoradiotherapy. Methods This non-randomised multicentre phase II trial r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5d177d589a602af4e52e02824331172
https://pubmed.ncbi.nlm.nih.gov/32619832
https://pubmed.ncbi.nlm.nih.gov/32619832
Autor:
Gjermund Johnsen, Anne-Birgitte Jacobsen, A. Ajengui, Mats Lindblad, Nils Glenjen, Lars Lundell, Asif Johar, Magnus Nilsson, B. Sunde, Fredrik Klevebro, Signe Friesland, Pernilla Lagergren
Publikováno v:
The British journal of surgeryReferences. 106(11)
There are few data comparing health-related quality of life (HRQoL) after neoadjuvant chemotherapy alone (nCT) compared with neoadjuvant chemoradiotherapy (nCRT) in patients with oesophageal cancer.In the NeoRes trial, patients were assigned randomly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad13a9c4683dad2e728d5e2f37a3fe68
https://pubmed.ncbi.nlm.nih.gov/31436322
https://pubmed.ncbi.nlm.nih.gov/31436322
Autor:
G. A. Von Döbeln, Jingru Yu, Nils Glenjen, Niels Hilmer Nielsen, Anne-Birgitte Jacobsen, Gjermund Johnsen, Hans-Olaf Johannessen, Magnus Nilsson, Fredrik Klevebro, Ingunn Hatlevoll, Signe Friesland, Lars Lundell
Publikováno v:
Diseases of the esophagus
NeoRes I is a randomized phase II trial comparing neoadjuvant chemoradiotherapy with neoadjuvant chemotherapy in the treatment of resectable cancer of the esophagus or gastroesophageal junction. Patients with biopsy-proven adenocarcinoma or squamous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b0faea69798dfd0b7579314ba491ce4
https://hdl.handle.net/11250/3048635
https://hdl.handle.net/11250/3048635
Publikováno v:
Ræbild, A, Høegh, K, Jacobsen, B, Kjær, E D & Meilby, H 2019, ' Det Grønlandske Arboret – ca. 40 år efter de første plantninger ', Dansk Dendrologisk Aarsskrift, bind 2019, s. 6-25 . < http://www.dendron.dk/aarsskrift/docs/211.pdf >
University of Copenhagen
University of Copenhagen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5dfbd94233051be7225b0a503e73ab05
https://curis.ku.dk/portal/da/publications/det-groenlandske-arboret--ca-40-aar-efter-de-foerste-plantninger(6994e7d6-6a76-42a7-a55b-6fadcef11784).html
https://curis.ku.dk/portal/da/publications/det-groenlandske-arboret--ca-40-aar-efter-de-foerste-plantninger(6994e7d6-6a76-42a7-a55b-6fadcef11784).html
Autor:
Magnus Nilsson, Anne-Birgitte Jacobsen, Fredrik Klevebro, Nils Glenjen, Lars Lundell, Gjermund Johnsen, Jon A. Tsai, Signe Friesland, Ingunn Hatlevoll, Pehr Lind, G. Alexandersson von Döbeln, N. Wang
Publikováno v:
Annals of Oncology. 27:660-667
Background Neoadjuvant therapy improves long-term survival after oesophagectomy, treating oesophageal cancer, but the evidence to date is insufficient to determine which of the two main neoadjuvant therapy types, chemotherapy (nCT) or chemoradiothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8fbbe1bad9d44eb2922f8ae2b014d407
https://doi.org/10.1093/annonc/mdw010
https://doi.org/10.1093/annonc/mdw010
Autor:
B. Sunde, Mats Lindblad, Gjermund Johnsen, Signe Friesland, Ioannis Rouvelas, Lars Lundell, Anne-Birgitte Jacobsen, Nils Glenjen, Pernilla Lagergren, Naning Wang, Magnus Nilsson
Publikováno v:
Diseases of the Esophagus. 32
Dysphagia is the most significant symptom in patients with esophageal cancer. There are different therapeutic interventions designed to relieve dysphagia, but few studies have addressed the effects of neoadjuvant therapy. The aim of this study is to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f651acdf16a127bf374c29e519118e45
https://doi.org/10.1093/dote/doy069
https://doi.org/10.1093/dote/doy069
Autor:
Anne-Birgitte Jacobsen, Gjermund Johnsen, Jon A. Tsai, Egil Johnson, T. Myrnas, Magnus Nilsson, Mats Lindblad, Fredrik Klevebro, Signe Friesland, Lars Lundell, Saga Persson, Asgaut Viste, Eva Szabo
Publikováno v:
European Journal of Surgical Oncology (EJSO). 41:920-926
Objective To compare the incidence and severity of postoperative complications after oesophagectomy for carcinoma of the oesophagus and gastro-oesophageal junction (GOJ) after randomized accrual to neoadjuvant chemotherapy (nCT) or neoadjuvant chemor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ae09bd29bd6a2bd5545a1a7f3df1623
https://doi.org/10.1016/j.ejso.2015.03.226
https://doi.org/10.1016/j.ejso.2015.03.226
Autor:
Anne Birgitte Jacobsen, Ragnhild Sørum Falk, Silje Skjelsvik Os, Cecilie Delphin Amdal, Egil Johnson, Trond Warloe, Kristin Bjordal
Publikováno v:
Acta oncologica (Stockholm, Sweden). 56(10)
Patients with esophageal cancer seldom achieve long-term survival. This prospective cohort study investigated the selection of patients likely to benefit from curative treatment and whether information on patients' health-related quality of life (HRQ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fe943f87c3728f0db58a66afb094d99
https://pubmed.ncbi.nlm.nih.gov/28686501
https://pubmed.ncbi.nlm.nih.gov/28686501